Clinical And Experimental Hypertension

Clinical And Experimental Hypertension

临床和实验性高血压

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Clinical And Experimental Hypertension》是由Informa Healthcare出版社于1993年创办的英文国际期刊(ISSN: 1064-1963,E-ISSN: 1525-6006),该期刊长期致力于外周血管病领域的创新研究,主要研究方向为医学-外周血管病。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0039...%),以发表外周血管病领域等方向的原创性研究为核心(研究类文章占比100.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在77篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical And Experimental Hypertension审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约77篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 77 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PERIPHERAL VASCULAR DISEASE 外周血管病 PHARMACOLOGY & PHARMACY 药学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PERIPHERAL VASCULAR DISEASE 外周血管病 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PERIPHERAL VASCULAR DISEASE SCIE Q3 67 / 96

30.7%

学科:PHARMACOLOGY & PHARMACY SCIE Q3 265 / 354

25.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PERIPHERAL VASCULAR DISEASE SCIE Q3 53 / 96

45.31%

学科:PHARMACOLOGY & PHARMACY SCIE Q3 243 / 354

31.5%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.9 SJR:0.448 SNIP:0.502
学科类别 分区 排名 百分位
大类:Medicine 小类:Internal Medicine Q2 78 / 167

53%

大类:Medicine 小类:Physiology Q3 123 / 193

36%

期刊发文

  • Inhibition of endoplasmic reticulum stress restores the balance of renal RAS components and lowers blood pressure in the spontaneously hypertensive rats

    Author: Zhu, Jun; Shao, Anjing; Wang, Chunyan; Zeng, Chensi; Wang, Hongyong

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2202367

  • Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension

    Author: Zhang, Min; Zeng, Qi; Zhou, Shan; Zhu, Gaizhi; Xu, Yaqi; Gao, Ran; Su, Wenting; Wang, Renxi

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2183963

  • MicroRNA-98 inhibition accelerates the development of atherosclerosis via regulation of dysfunction of endothelial cell

    Author: Yu, Huai; Cao, Hui; Yu, Hang

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2206068

  • GSDMD-mediated pyroptosis promotes cardiac remodeling in pressure overload

    Author: You, Jieyun; Li, Xuan; Dai, Fangjie; Liu, Jun; Zhang, Qi; Guo, Wei

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2189138

  • Association of triglycerides to high density lipoprotein cholesterol ratio with hypertension in Chinese adults: a cross-sectional study

    Author: Yi, Qianglin; Hu, Hui; Zeng, Qingfan

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2195996

  • Correlation between pulmonary vascular performance and hemodynamics in patients with pulmonary arterial hypertension

    Author: Yasenjiang, Maimaiti; Cheng, Hui; Guo, Zitong; Yu, Xiaolin; Adilijiang, Tuohuti; Li, Guoqing

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2185253

  • Gut microbiota and hypertension: association, mechanisms and treatment

    Author: Yang, Zhihua; Wang, Qingchun; Liu, Yangxi; Wang, Lin; Ge, Zhao; Li, Zhenzhen; Feng, Shaoling; Wu, Chongming

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2195135

  • Circ-USP9X interacts with EIF4A3 to promote endothelial cell pyroptosis by regulating GSDMD stability in atherosclerosis

    Author: Xu, Shengkai; Ge, Yishan; Wang, Xuebin; Yin, Wei; Zhu, Xiaoqing; Wang, Jie; Qiao, Shigang

    Journal: CLINICAL AND EXPERIMENTAL HYPERTENSION. 2023; Vol. 45, Issue 1, pp. -. DOI: 10.1080/10641963.2023.2186319